Kyoto, Japan

Satoru Ikegami



Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1994-2018

Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: Satoru Ikegami: Pioneering Innovations in Pharmaceutical Technology

Introduction:

Satoru Ikegami, a visionary inventor based in Kyoto, JP, has garnered acclaim for his relentless pursuit of excellence in the realm of technology. With a total of 8 patents to his name, Ikegami's contributions have significantly shaped the landscape of the pharmaceutical industry and beyond.

Latest Patents:

Among his latest patents is the groundbreaking "4-alkynyl imidazole derivative and medicine comprising same as active ingredient." This invention showcases Ikegami's expertise in developing pharmaceuticals with superior EP4 receptor antagonistic action, proving invaluable in the treatment of inflammatory diseases, pain management, and immune-related conditions.

Career Highlights:

Throughout his illustrious career, Ikegami has made significant strides in the field of pharmaceutical research and development. Notably, he has lent his expertise to renowned companies such as Kaken Pharmaceutical Company, Ltd. and the Molecular Research Institute, where his innovative mindset has led to the creation of groundbreaking solutions.

Collaborations:

In his collaborative efforts, Ikegami has had the pleasure of working alongside esteemed colleagues such as Hidenori Funamizu and Nobuo Ishiyama. Together, they have pushed the boundaries of pharmaceutical innovation, paving the way for new advancements in the industry.

Conclusion:

Satoru Ikegami's passion for innovation and his unwavering dedication to excellence have cemented his status as a trailblazing inventor in the world of technology. His inventive spirit continues to drive progress and inspire future generations of inventors to think boldly and push the limits of what is possible in the realm of pharmaceuticals and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…